Literature DB >> 22030550

Cerebrovascular disorders: molecular insights and therapeutic opportunities.

Erik Storkebaum1, Annelies Quaegebeur, Miikka Vikkula, Peter Carmeliet.   

Abstract

Blood vessels in the nervous system have traditionally been considered neutral bystanders that only passively adapt their structure and function in response to the needs of neural cells. Emerging evidence suggests, however, that vessels and angiogenic molecules actively participate in the pathogenesis of neurological disorders. Here we will discuss molecular insights into neurological disorders resulting either from excessive vessel growth (cerebral vascular malformations) or improper vessel regression (neurodegeneration and white matter lesions). These genetic insights offer alternative therapeutic options, some of which are being evaluated in the clinic.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22030550     DOI: 10.1038/nn.2947

Source DB:  PubMed          Journal:  Nat Neurosci        ISSN: 1097-6256            Impact factor:   24.884


  100 in total

Review 1.  Neurovascular regulation in the normal brain and in Alzheimer's disease.

Authors:  Costantino Iadecola
Journal:  Nat Rev Neurosci       Date:  2004-05       Impact factor: 34.870

Review 2.  RNA processing pathways in amyotrophic lateral sclerosis.

Authors:  Marka van Blitterswijk; John E Landers
Journal:  Neurogenetics       Date:  2010-03-27       Impact factor: 2.660

3.  Capillary vessel wall in CADASIL angiopathy.

Authors:  Eliza Lewandowska; Grazyna M Szpak; Teresa Wierzba-Bobrowicz; Joanna Modzelewska; Tomasz Stepień; Elzbieta Pasennik; Bogna Schmidt-Sidor; Janina Rafałowska
Journal:  Folia Neuropathol       Date:  2010       Impact factor: 2.038

Review 4.  Hereditary hemorrhagic telangiectasia: from molecular biology to patient care.

Authors:  S Dupuis-Girod; S Bailly; H Plauchu
Journal:  J Thromb Haemost       Date:  2010-03-19       Impact factor: 5.824

5.  Stabilization of VEGFR2 signaling by cerebral cavernous malformation 3 is critical for vascular development.

Authors:  Yun He; Haifeng Zhang; Luyang Yu; Murat Gunel; Titus J Boggon; Hong Chen; Wang Min
Journal:  Sci Signal       Date:  2010-04-06       Impact factor: 8.192

6.  A novel mouse model of cerebral cavernous malformations based on the two-hit mutation hypothesis recapitulates the human disease.

Authors:  David A McDonald; Robert Shenkar; Changbin Shi; Rebecca A Stockton; Amy L Akers; Melanie H Kucherlapati; Raju Kucherlapati; James Brainer; Mark H Ginsberg; Issam A Awad; Douglas A Marchuk
Journal:  Hum Mol Genet       Date:  2010-10-11       Impact factor: 6.150

7.  Control of motoneuron survival by angiogenin.

Authors:  Dairín Kieran; Jordi Sebastia; Matthew J Greenway; Matthew A King; Dervla Connaughton; Caoimhin G Concannon; Beau Fenner; Orla Hardiman; Jochen H M Prehn
Journal:  J Neurosci       Date:  2008-12-24       Impact factor: 6.167

8.  Decreased glucose transporters correlate to abnormal hyperphosphorylation of tau in Alzheimer disease.

Authors:  Ying Liu; Fei Liu; Khalid Iqbal; Inge Grundke-Iqbal; Cheng-Xin Gong
Journal:  FEBS Lett       Date:  2008-01-02       Impact factor: 4.124

9.  VEGF delivery with retrogradely transported lentivector prolongs survival in a mouse ALS model.

Authors:  Mimoun Azzouz; G Scott Ralph; Erik Storkebaum; Lucy E Walmsley; Kyriacos A Mitrophanous; Susan M Kingsman; Peter Carmeliet; Nicholas D Mazarakis
Journal:  Nature       Date:  2004-05-27       Impact factor: 49.962

10.  The cerebral cavernous malformation signaling pathway promotes vascular integrity via Rho GTPases.

Authors:  Kevin J Whitehead; Aubrey C Chan; Sutip Navankasattusas; Wonshill Koh; Nyall R London; Jing Ling; Anne H Mayo; Stavros G Drakos; Christopher A Jones; Weiquan Zhu; Douglas A Marchuk; George E Davis; Dean Y Li
Journal:  Nat Med       Date:  2009-01-18       Impact factor: 53.440

View more
  29 in total

1.  Alzheimer's disease: A breach in the blood-brain barrier.

Authors:  Peter Carmeliet; Bart De Strooper
Journal:  Nature       Date:  2012-05-23       Impact factor: 49.962

2.  Tol2 gene trap integrations in the zebrafish amyloid precursor protein genes appa and aplp2 reveal accumulation of secreted APP at the embryonic veins.

Authors:  Hsin-Kai Liao; Ying Wang; Kristin E Noack Watt; Qin Wen; Justin Breitbach; Chelsy K Kemmet; Karl J Clark; Stephen C Ekker; Jeffrey J Essner; Maura McGrail
Journal:  Dev Dyn       Date:  2012-02       Impact factor: 3.780

Review 3.  Recent molecular discoveries in angiogenesis and antiangiogenic therapies in cancer.

Authors:  Jonathan Welti; Sonja Loges; Stefanie Dimmeler; Peter Carmeliet
Journal:  J Clin Invest       Date:  2013-08-01       Impact factor: 14.808

Review 4.  Vascular remodeling after ischemic stroke: mechanisms and therapeutic potentials.

Authors:  Jialing Liu; Yongting Wang; Yosuke Akamatsu; Chih Cheng Lee; R Anne Stetler; Michael T Lawton; Guo-Yuan Yang
Journal:  Prog Neurobiol       Date:  2013-11-27       Impact factor: 11.685

Review 5.  An endothelial link between the benefits of physical exercise in dementia.

Authors:  Lianne J Trigiani; Edith Hamel
Journal:  J Cereb Blood Flow Metab       Date:  2017-06-15       Impact factor: 6.200

6.  Neurovascular crosstalk between interneurons and capillaries is required for vision.

Authors:  Yoshihiko Usui; Peter D Westenskow; Toshihide Kurihara; Edith Aguilar; Susumu Sakimoto; Liliana P Paris; Carli Wittgrove; Daniel Feitelberg; Mollie S H Friedlander; Stacey K Moreno; Michael I Dorrell; Martin Friedlander
Journal:  J Clin Invest       Date:  2015-04-27       Impact factor: 14.808

7.  Micro-endoscopy for Live Small Animal Fluorescent Imaging.

Authors:  Bjorn Paulson; Jun Ki Kim
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

8.  Early Phase PIB-PET as a Surrogate for Global and Regional Cerebral Blood Flow Measures.

Authors:  Laura L Boles Ponto; David J Moser; Yusuf Menda; Emily L Harlynn; Sean D DeVries; Jacob J Oleson; Vincent A Magnotta; Susan K Schultz
Journal:  J Neuroimaging       Date:  2018-11-21       Impact factor: 2.486

9.  Systemic and cerebral exposure to and pharmacokinetics of flavonols and terpene lactones after dosing standardized Ginkgo biloba leaf extracts to rats via different routes of administration.

Authors:  Feng Chen; Li Li; Fang Xu; Yan Sun; Feifei Du; Xutao Ma; Chenchun Zhong; Xiuxue Li; Fengqing Wang; Nating Zhang; Chuan Li
Journal:  Br J Pharmacol       Date:  2013-09       Impact factor: 8.739

10.  Microvascular lesions by estrogen-induced ID3: its implications in cerebral and cardiorenal vascular disease.

Authors:  Jayanta K Das; Quentin Felty
Journal:  J Mol Neurosci       Date:  2014-08-17       Impact factor: 3.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.